Sung Chang Kyu, Kim See Hyung, Woo Sungmin, Moon Min Hoan, Kim Sang Youn, Kim Seung Hyup, Cho Jeong Yeon
Department of Radiology, Seoul National University College of Medicine and SNU-SMG Boramae Medical Center, Seoul, Republic of Korea.
Department of Radiology, Keimyung University College of Medicine, Daegu, Republic of Korea.
Acta Radiol. 2016 Sep;57(9):1114-22. doi: 10.1177/0284185115618547. Epub 2015 Dec 11.
Angiomyolipoma (AML) with minimal fat may mimic renal cell carcinoma (RCC) and is difficult to distinguish from RCC with imaging studies alone. Precise diagnostic strategies have been explored to discern AML with minimal fat from RCC.
To compare the morphological and enhancement features of AML with minimal fat with those of size-matched RCC on computed tomography (CT).
Our study included 143 pathologically proved renal tumors (29 AML with minimal fat: mean diameter, 2.5 cm; range, 1.2-4 cm; 114 RCC: mean diameter, 2.8 cm; range, 1.3-4 cm). All patients underwent biphasic helical CTs. Two radiologists retrospectively evaluated the morphological (i.e. non-round and round appearances, with or without capsule) and enhancement features (i.e., wash-out, gradual, or prolonged). For the parameters that had statistically significance between the two groups, we calculated the positive and negative predictive values by using the univariate χ(2) test. P < 0.05 indicated a significant difference.
AML with minimal fat showed a non-round appearance without a capsule (n = 24, 83%) and prolonged enhancement (n = 20, 69%). The positive and negative predictive values of the non-round appearance without capsule for differentiating AML with minimal fat from RCC were 82.8% and 95.6%, respectively. The positive and negative predictive values of prolonged enhancement were 62.5% and 90.8%, respectively. These features were valuable predictors for AML with minimal fat from RCC.
CT images with non-round shape without capsule and prolonged enhancements may be used to differentiate AML with minimal fat from RCC.
脂肪含量极少的肾血管平滑肌脂肪瘤(AML)可能会与肾细胞癌(RCC)相似,仅通过影像学检查很难将其与RCC区分开来。目前已经探索了精确的诊断策略来鉴别脂肪含量极少的AML和RCC。
比较脂肪含量极少的AML与大小匹配的RCC在计算机断层扫描(CT)上的形态学和强化特征。
我们的研究纳入了143例经病理证实的肾肿瘤(29例脂肪含量极少的AML:平均直径2.5 cm;范围1.2 - 4 cm;114例RCC:平均直径2.8 cm;范围1.3 - 4 cm)。所有患者均接受了双期螺旋CT检查。两名放射科医生回顾性评估了形态学特征(即非圆形和圆形外观,有无包膜)和强化特征(即廓清、渐进性或持续性)。对于两组间具有统计学意义的参数,我们采用单因素χ²检验计算阳性和阴性预测值。P < 0.05表示差异有统计学意义。
脂肪含量极少的AML表现为无包膜的非圆形外观(n = 24,83%)和持续性强化(n = 20,69%)。无包膜的非圆形外观用于鉴别脂肪含量极少的AML与RCC的阳性和阴性预测值分别为82.8%和95.6%。持续性强化的阳性和阴性预测值分别为62.5%和90.8%。这些特征是鉴别脂肪含量极少的AML与RCC的有价值的预测指标。
无包膜的非圆形形状和持续性强化的CT图像可用于鉴别脂肪含量极少的AML与RCC。